AFT Pharmaceuticals (NZSE:AFT) Forward Dividend Yield %: 0.68% (As of Jun. 27, 2026)


NZSE:AFT AFT Pharmaceuticals Ltd NZSE:AFT
96 GF Score
Price NZ$3.68
GF Value NZ$4.15
Valuation Modestly Undervalued
! 3 Warning Signs
View Full Analysis

What is AFT Pharmaceuticals Forward Dividend Yield %?

AFT Pharmaceuticals NZSE:AFT +0.27% 96 Forward Dividend Yield % is 0.68% as of Jun. 27, 2026. GuruFocus rates NZSE:AFT with a GF Score™ of 96/100 and a GF Value™ of NZ$4.15 (Modestly Undervalued). The stock has 3 warning signs investors should review. Among 504 Drug Manufacturers companies, AFT Pharmaceuticals ranks worse than 77.78% on this metric.

As of today (2026-06-27), the Forward Annual Dividend Yield of AFT Pharmaceuticals is 0.68%.

As of today (2026-06-27), the Trailing Annual Dividend Yield of AFT Pharmaceuticals is 0.68%.

NZSE:AFT's Forward Dividend Yield % is ranked worse than
77.78% of 504 companies
in the Drug Manufacturers industry
Industry Median: 2.08 vs NZSE:AFT: 0.68

AFT Pharmaceuticals's Dividends per Share for the six months ended in Mar. 2026 was NZ$0.00.

During the past 12 months, AFT Pharmaceuticals's average Dividends Per Share Growth Rate was 12.50% per year.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.


AFT Pharmaceuticals  (NZSE:AFT) Forward Dividend Yield % Explanation

Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.

Dividends may also qualify a lower tax rate for investors.

In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

You can find the stocks that owned most by Gurus here. Or you can check out Warren Buffett's highest dividend stocks here.


AFT Pharmaceuticals Forward Dividend Yield % Related Terms


NZSE:AFT vs ZTS, UTHR, VTRS: Forward Dividend Yield % Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, AFT Pharmaceuticals's Forward Dividend Yield %, along with its competitors' market caps and Forward Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


AFT Pharmaceuticals Forward Dividend Yield % vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, AFT Pharmaceuticals's Forward Dividend Yield % distribution charts can be found below:

* The bar in red indicates where AFT Pharmaceuticals's Forward Dividend Yield % falls into.


NZSE:AFT
96GF Score
AFT Pharmaceuticals Ltd NZSE:AFT
Forward Dividend Yield % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

AFT Pharmaceuticals Forward Dividend Yield % Calculation

Dividend Yield measures how much a company pays out in dividends each year relative to its share price.

AFT Pharmaceuticals Recent Full-Year* Dividend History

Amount Ex-date Record Date Pay Date Type Frequency Forex Rate
NZD 0.0250002026-06-182026-06-192026-07-03Cash DividendannuallyNZD:NZD 1.000000

* GuruFocus has an internal rule that if the most recent dividend payment frequency is at least 4 times a year, then the full year will be calculated according to the frequency of payment or the one-year time frame, whichever is stricter.
* GuruFocus converts dividend currency to local traded share price currency in order to calculate dividend yield. Please refer to the last column "Forex Rate" in the above table.

AFT Pharmaceuticals's Forward Annual Dividend Yield (%) for Today is calculated as

Forward Annual Dividend Yield=Forward Full Year Dividend/Current Share Price
=0.025/3.68
=0.68 %

Current Share Price is NZ$3.68.
AFT Pharmaceuticals's Dividends per Share for the forward twelve months is calculated as NZ$0.025 * 1 = NZ$0.025.

AFT Pharmaceuticals's Trailing Annual Dividend Yield (%) for Today is calculated as

Trailing Annual Dividend Yield=Most Recent Full Year Dividend/Current Share Price
=0.025/3.68
=0.68 %

Current Share Price is NZ$3.68.
AFT Pharmaceuticals's Dividends per Share for the trailing twelve months (TTM) ended in Today is NZ$0.025.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Forward Dividend Yield % of 0.68% mean?
AFT Pharmaceuticals (NZSE:AFT) has a Forward Dividend Yield % of 0.68% as of Jun. 27, 2026. Forward dividend yield is the ratio of company's expected dividends to the share price. View historical data on AFT Pharmaceuticals and its competitors. According to the industry distribution chart, AFT Pharmaceuticals ranks #392 out of 504 companies in the Drug Manufacturers industry, placing it in the top 77.8%.
Is AFT Pharmaceuticals' Forward Dividend Yield % too high?
AFT Pharmaceuticals' current Forward Dividend Yield % is 0.68%. The Drug Manufacturers industry median Forward Dividend Yield % is 2.08. AFT Pharmaceuticals' value of 0.68% is 67.3% below this industry median. Based on the distribution chart, AFT Pharmaceuticals ranks #392 out of 504 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, AFT Pharmaceuticals has a GF Score™ of 96/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does AFT Pharmaceuticals' Forward Dividend Yield % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, AFT Pharmaceuticals ranks #392 out of 504 companies for Forward Dividend Yield %. This places AFT Pharmaceuticals in the lower half of its industry. The industry median Forward Dividend Yield % is 2.08. AFT Pharmaceuticals' value of 0.68% is 67.3% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Forward Dividend Yield % for a Drug Manufacturers company?
The median Forward Dividend Yield % among Drug Manufacturers companies is 2.08, based on 504 companies in the industry. Companies in the top quartile (top 25%) have a Forward Dividend Yield % significantly above this median, while those in the bottom quartile fall well below. However, Forward Dividend Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. AFT Pharmaceuticals's current Forward Dividend Yield % of 0.68% is 67.3% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Forward Dividend Yield % mean?
A high Forward Dividend Yield % can signal that a stock is expensive relative to its fundamentals. Forward dividend yield is the ratio of company's expected dividends to the share price. View historical data on AFT Pharmaceuticals and its competitors. For the Drug Manufacturers industry, the median Forward Dividend Yield % is 2.08 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. AFT Pharmaceuticals's current Forward Dividend Yield % is 0.68%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is AFT Pharmaceuticals stock overvalued right now?
Based on GuruFocus' analysis, AFT Pharmaceuticals (NZSE:AFT) is currently considered Modestly Undervalued. The stock's GF Value™ is NZ$4.15, compared to a current price of NZ$3.68 — trading 11.3% below its estimated fair value. The current Forward Dividend Yield % is 0.68% and 67.3% below the Drug Manufacturers industry median of 2.08. AFT Pharmaceuticals' overall GF Score™ is 96/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Forward Dividend Yield % calculated?
Forward Dividend Yield % is calculated from a company's financial statements. For AFT Pharmaceuticals (NZSE:AFT), the current Forward Dividend Yield % is 0.68% as of Jun. 27, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is AFT Pharmaceuticals (NZSE:AFT) Overvalued in 2026?

Based on GuruFocus' analysis, AFT Pharmaceuticals stock appears to be undervalued. The current stock price of NZ$3.68 is trading 11.3% below its estimated GF Value™ of NZ$4.15. GuruFocus considers AFT Pharmaceuticals to be Modestly Undervalued.

Key valuation signals for NZSE:AFT:

  • Forward Dividend Yield %: 0.68%
  • GF Value™: NZ$4.15 vs. price of NZ$3.68 (11.3% below fair value)
  • GF Score™: 96/100 with 3 warning signs
  • Industry Position: 67.3% below the Drug Manufacturers median (#392 of 504)

No single metric tells the full story. See the NZSE:AFT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


AFT Pharmaceuticals Business Description

Other Exchanges AFP:Australia
Address 129 Hurstmere Road, Level 1, Takapuna, Auckland, NTL, NZL, 0622
AFT Pharmaceuticals Ltd is a pharmaceutical distributor and developer of pharmaceutical intellectual property. Some of the products of the organization are Maxigesic dose forms, Capsaicin creams, Crystaderm, Kiwisoothe, Micolette, and others. The group has four operating segments based on geographical location being Australia, New Zealand, Asia, and the Rest of the world. It generates the majority of the revenue from Australia, which includes the sales and distribution activity relating to the Australian market.
96GF Score

Get the complete analysis for NZSE:AFT

Forward Dividend Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NZ$3.68
Price
NZ$4.15
GF Value